414 related articles for article (PubMed ID: 21091384)
1. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
Morais P; Baudrier T; Mota A; Cunha AP; Alves M; Neves C; Capela J; Sá-Couto P; Azevedo F
Cutan Ocul Toxicol; 2011 Jun; 30(2):147-53. PubMed ID: 21091384
[TBL] [Abstract][Full Text] [Related]
2. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics of propylthiouracil (PTU) induced antineutrophil cytoplasmic antibodies positive cases; analysis of a case of PTU-induced ANCA positive patients with hyperthyroidism].
Li MT; Zeng XJ; Fang WG; Li H; Li XM; Feng K; Li YZ; Zeng XF; Zhang FC; Tang FL
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2082-5. PubMed ID: 15730621
[TBL] [Abstract][Full Text] [Related]
4. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review].
Xu X; Zhao M; Zhang Y; Guo X; Wang H
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):404-7. PubMed ID: 12137604
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil.
Cin MO; Gursoy A; Morris Y; Aydintug OT; Kamel N; Gullu S
Int J Clin Pract; 2009 Feb; 63(2):299-302. PubMed ID: 19196368
[TBL] [Abstract][Full Text] [Related]
9. PTU-associated cutaneous vasculitis with ANCA anti-MPO and anti-PR3 antibodies.
Jacobs EM; Hartkamp A; Kaasjager HA
Neth J Med; 2003 Sep; 61(9):296-9. PubMed ID: 14692444
[TBL] [Abstract][Full Text] [Related]
10. Recurrent episodes of arthritis in a hyperthyroid patient.
Tan F; Nam TQ; Lee KO; Cheah WK; Mukherjee JJ
Singapore Med J; 2006 Feb; 47(2):163-5. PubMed ID: 16435062
[TBL] [Abstract][Full Text] [Related]
11. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
[TBL] [Abstract][Full Text] [Related]
12. Propylthiouracil-induced hypersensitivity syndrome.
Aycan Z; Arhan E; Cetinkaya E; Vidinlisan S; Menekşe N; Yücel H; Cakar N
Turk J Pediatr; 2006; 48(2):162-5. PubMed ID: 16848120
[TBL] [Abstract][Full Text] [Related]
13. Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment.
Yazisiz V; Ongüt G; Terzioğlu E; Karayalçin U
Int J Clin Pract; 2010 Jan; 64(1):19-24. PubMed ID: 18284438
[TBL] [Abstract][Full Text] [Related]
14. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
[TBL] [Abstract][Full Text] [Related]
15. Propylthiouracil-induced ANCA-positive erythema nodosum treated with thalidomide.
Wan P; Zhao X; Hunasehally RY; Shi R; Zheng J
Int J Dermatol; 2012 Mar; 51(3):345-8. PubMed ID: 22348574
[TBL] [Abstract][Full Text] [Related]
16. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
[TBL] [Abstract][Full Text] [Related]
17. [A pediatric case of myeloperoxidase-antineutrophil cytoplasmic (ANCA)-related crescentic glomerulonephritis associated with propylthiouracil treatment for Graves' disease].
Kawasaki Y; Suzuki J; Sike T; Isome M; Nozawa R; Suzuki S; Kume K; Suzuki H
Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):612-7. PubMed ID: 9893462
[TBL] [Abstract][Full Text] [Related]
18. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
Guo XH; Zhao MH; Gao Y; Wang SF; Gao Y
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):932-5. PubMed ID: 12899790
[TBL] [Abstract][Full Text] [Related]
19. Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies.
Kudoh Y; Kuroda S; Shimamoto K; Iimura O
Clin Nephrol; 1997 Jul; 48(1):41-3. PubMed ID: 9247777
[TBL] [Abstract][Full Text] [Related]
20. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.
Yang J; Yao LP; Dong MJ; Xu Q; Zhang J; Weng WW; Chen F
Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
